A Decrease in Serum Aldosterone Level is Associated with Maintenance of Sinus Rhythm after Successful Cardioversion of Atrial Fibrillation
- 4 January 2010
- journal article
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 33 (5) , 561-565
Abstract
The activation of the renin-angiotensin-aldosterone system has been implicated in the progression of atrial structural remodeling during atrial fibrillation (AF). However, consequences of the changes of aldosterone in AF have not been evaluated. This study's aim was to evaluate changes of serum aldosterone concentration after successful cardioversion of persistent AF and to determine the prognostic value of these changes. The prospective, single center study included 45 consecutive patients with nonvalvular persistent AF and preserved left ventricular systolic function, referred for cardioversion. None of the patients were taking aldosterone antagonists. Blood samples for aldosterone measurement were collected twice: 24 hours before and 24 hours after cardioversion. Forty-three patients were successfully converted to sinus rhythm. On the 30th day following cardioversion, 24 patients maintained sinus rhythm (group A), 19 patients relapsed to AF (group B). Serum aldosterone concentration before cardioversion did not differ significantly between both groups (175.6 +/- 112.82 pg/mL vs 125.8 +/- 51.2 pg/mL; P = 0.25). However, in group A serum aldosterone level decreased significantly within 24 hours after cardioversion, from 175.6 +/- 112.8 pg/mL to 101.4 +/- 44.2 pg/mL (P = 0.0034). In group B, the aldosterone level before and after cardioversion did not differ significantly (125.8 +/- 51.2 pg/mL vs 118.2 +/- 59.6 pg/mL; P = 0.68). Logistic regression analysis revealed that a decrease in plasma aldosterone concentration after direct current cardioversion more than 13.2 pg/mL predicted sinus rhythm maintenance in a 30-day follow-up, with 87% sensitivity and 64% specificity. There is a positive correlation between the fall in aldosterone concentration 24 hours after cardioversion and maintenance of sinus rhythm during 30 days of observation.Keywords
This publication has 12 references indexed in Scilit:
- Aldosterone Synthase Gene Polymorphism as a Determinant of Atrial Fibrillation in Patients With Heart FailureThe American Journal of Cardiology, 2008
- Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programAmerican Heart Journal, 2006
- Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidenceEuropean Heart Journal, 2005
- Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRMHeart Rhythm, 2004
- Enalapril Decreases the Incidence of Atrial Fibrillation in Patients With Left Ventricular DysfunctionCirculation, 2003
- Aldosterone-induced cardiac damage: focus on blood pressure independent effectsAmerican Journal of Hypertension, 2003
- Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial FibrillationCirculation, 2002
- Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillationThe American Journal of Cardiology, 2001
- Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillationJACC, 2000
- Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation.Heart, 1990